Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lixisenatide

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Sanofi · Phase 3 · Completed · Enrollment 319

NCT00976937

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

18.411.9
≥5%
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
Lixisenatide18.4%n/rn/rn/r
Sitagliptin11.9%n/rn/rn/r

Not shown

Every selected arm is drawn.